Effect of a Weight Loss and Lifestyle Intervention on Dietary Behavior in Men with Obstructive Sleep Apnea: The INTERAPNEA Trial
Metadatos
Mostrar el registro completo del ítemAutor
Carneiro Barrera, Almudena; Amaro Gahete, Francisco José; Jurado Fasoli, Lucas; Sáez Roca, Germán; Martín Carrasco, Carlos; Ruiz Ruiz, JonatanEditorial
MDPI
Materia
Obstructive sleep apnea Obesity Weight loss Lifestyle intervention Dietary behavior Mediterranean diet
Fecha
2022-06-30Referencia bibliográfica
Carneiro-Barrera, A... [et al.]. Effect of a Weight Loss and Lifestyle Intervention on Dietary Behavior in Men with Obstructive Sleep Apnea: The INTERAPNEA Trial. Nutrients 2022, 14, 2731. [https://doi.org/10.3390/nu14132731]
Patrocinador
Spanish Government FPU16/01093 FPU14/04172 FPU19/01609; University of Granada-LoMonaco S.L. Sleep Research Cathedra University of Granada Plan Propio de Investigacion 2016-Excellence actions: Unit of Excellence on Exercise and Health (UCEES); Regional Ministry of Economy, Knowledge, Enterprise, and Universities (CECEU) of Andalusia (European Regional Development Funds) SOMM17/6107/UGRResumen
This study investigated the effects of an eight-week interdisciplinary weight loss and
lifestyle intervention on dietary behavior in men who were overweight/had obesity and moderateto-
severe obstructive sleep apnea (OSA). It was based on data from INTERAPNEA (ClinicalTrials.gov
ID: NCT03851653); a randomized clinical trial conducted from April 2019 to April 2020. Men
aged 18–65 years with moderate-to-severe OSA and a body mass index 25 kg/m2 were randomly
assigned to a usual-care group or an eight-week interdisciplinary weight loss and lifestyle intervention
combined with usual-care. Dietary behavior was assessed through the Food Behavior Checklist (FBC)
and the Mediterranean Diet Adherence Screener (MEDAS). Of the 89 participants who underwent
randomization, 75 completed the intervention endpoint assessment, 89 participants being therefore
included in the intention-to-treat analyses, and 75 in the per-protocol approach. As compared with
usual-care, the intervention group had greater improvements at intervention endpoint in dietary
behavior, as measured by the FBC total score (20% increase in FBC total score, mean between-group
difference, 8.7; 95% confidence interval, 5.7 to 11.7), and MEDAS total score (33% increase in MEDAS
total score, mean between-group difference, 2.1; 95% CI 1.3 to 2.9). At 6 months after intervention,
the intervention group also had greater improvements in both the FBC total score (15% increase) and
MEDAS total score (25% increase), with mean between-group differences of 7.7 (CI 95%, 4.4 to 10.9)
and 1.7 (CI 95%, 0.9 to 2.6), respectively. An eight-week interdisciplinary weight loss and lifestyle
intervention resulted in meaningful and sustainable improvements in dietary behavior, including
adherence to the Mediterranean diet in men who were overweight/ had obesity and CPAP-treated
moderate-to-severe OSA.